The identification of tau mutations associated with frontotemporal dementia with parkinsonism on chromosome 17 (FTDP-17) [7,8] establishes the pathogenic role of tau in mediating neurodegeneration and cognitive decline. The gene discussed is MAPT; the disease is Mental deterioration.